I thought this review article did a good job explaining some big studies and what we can extrapolate about pros and cons of various ARBs. https://t.co/vA9vkHDUEa
@drjohnm There’s no “one best ARB”; choice depends on the patient (eg. gout? telmisartan). Useful review here https://t.co/yr24EfrZUd
@NanouTheNomad I've been on a telmi fad lately! This paper seemed pretty helpful: https://t.co/vA9vkHDUEa
RT @shivadas29: @JohnRMontford proteinuria was not the primary end point in any of the irbesartan trial as far as this paper is reffered 2…
@JohnRMontford proteinuria was not the primary end point in any of the irbesartan trial as far as this paper is reffered 2016 peer reviewed pub https://t.co/aftlmXRxDt The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?
RT @pzhong2016: Always wonder about this question: Different Therapeutic Choices with ARBs. Which One to Give? When? Why?https://t.co/iKHt…
Always wonder about this question: Different Therapeutic Choices with ARBs. Which One to Give? When? Why?https://t.co/iKHt8q1lpV https://t.co/ZQyyBPwZBD
The Different Therapeutic Choices with ARBs. Which One to Give? When? Why? https://t.co/KTUIdNaUDF
@WithoutHisEyes If you really want to get in the nerd weeds here, Losartan is the main (? Only) ARB proven to lower stroke risk— happens to be patient in story!— and many consider first line ARB in that setting. https://t.co/cdlVKRmV01
RT @prof_brunt: @picardonhealth @carlyweeks @Globe_Health #Valsartan and other ARB choices, like candesartan (also generic) https://t.co/QR…
@picardonhealth @carlyweeks @Globe_Health #Valsartan and other ARB choices, like candesartan (also generic) https://t.co/QRQNwNJBSi
RT @Saudi_Pharma: The Different Therapeutic Choices with ARBs. Which One to Give? When? Why? https://t.co/KAdsU8A1MU
RT @Saudi_Pharma: The Different Therapeutic Choices with ARBs. Which One to Give? When? Why? https://t.co/KAdsU8A1MU
RT @Saudi_Pharma: The Different Therapeutic Choices with ARBs. Which One to Give? When? Why? https://t.co/KAdsU8A1MU
Las diferentes opciones terapéuticas con ARA II. ¿Cuál de ellos dar? ¿Cuándo? ¿Por qué? https://t.co/WQRisjn8zt
The Different Therapeutic Choices with ARBs. Which One to Give? When? Why? | SpringerLink https://t.co/OSk6qCa4Hd